| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |